PRESS RELEASES

All Releases
Oct 03, 2002
Pain Therapeutics to Present at the UBS Warburg Global Life Sciences Conference SOUTH SAN FRANCISCO, Calif., Oct 3, 2002 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced that Remi Barbier, Pain Therapeutics' president and chief executive officer, is scheduled
Oct 01, 2002
Pain Therapeutics Successfully Completes Two Multi-dose Safety Studies SOUTH SAN FRANCISCO, Calif., Oct 1, 2002 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced that it has completed two safety studies using multi-doses of OxyTrex(TM) and MorViva(TM), its two
Aug 08, 2002
Pain Therapeutics Announces Second Quarter 2002 Financial Results SOUTH SAN FRANCISCO, Calif., Aug 08, 2002 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today reported financial results for the three and six months ended June 30, 2002.
Jul 11, 2002
Pain Therapeutics Announces Inclusion in Russell Indexes SOUTH SAN FRANCISCO, Calif., Jul 11, 2002 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced that its common stock has been included in both the broad market Russell 3000(R) Index and the small-cap Russell
Jun 25, 2002
Pain Therapeutics' President and CEO Wins Prestigious Entrepreneur Of The Year Award SOUTH SAN FRANCISCO, Calif., Jun 25, 2002 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced that its founder, president and chief executive officer, Remi Barbier, was named
Jun 10, 2002
Pain Therapeutics to Hold Conference Call SOUTH SAN FRANCISCO, Calif., Jun 10, 2002 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced that it will hold a mid-year clinical update conference call on Thursday, June 13 at 1:15 p.m. Pacific Time/4:15 p.m.
May 31, 2002
Pain Therapeutics Holds Annual Meeting SOUTH SAN FRANCISCO, Calif., May 31, 2002 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced that it held its Annual Meeting of Stockholders on May 30, 2002 as scheduled. A quorum of shareholders was present in person or by
May 01, 2002
Pain Therapeutics Completes Clinical Study Ahead of Schedule SOUTH SAN FRANCISCO, Calif., May 1, 2002 -- Novel Painkiller Tested in Patients with Post-Operative Pain Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced it has completed patient enrollment in a Phase II
Apr 10, 2002
Pain Therapeutics to Present at Two Investor Conferences SOUTH SAN FRANCISCO, Calif., April 10 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced that management will present at two investor conferences. The Company presentation will be given at the Thomas Weisel
Apr 04, 2002
Pain Therapeutics Expands Patent Portfolio for Novel Pain Medications SOUTH SAN FRANCISCO, Calif., Apr 4, 2002 /PRNewswire via COMTEX/ -- Pain Therapeutics, Inc., (Nasdaq: PTIE), a medical research company, today announced a significant expansion of its patent portfolio.